Haus Bioceuticals: Clinical Trials

5 trials sponsored by Haus Bioceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 4 Phase 2, 3 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 13Completed 3
Phase 41Completed 1

Follow Haus Bioceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
HAT01H Cream, Vehicle Cream - Atopic Dermatitis, Eczema
Phase 1 / Phase 2CompletedHaus Bioceuticals302017-03-262018-11-07
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
HAT1, Saline Solution - Healthy, Atopic Dermatitis
Phase 4CompletedHaus Bioceuticals1822016-04-012018-11-06
Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis
HAT1 topical cream, Vehicle cream - Dermatitis, Atopic
Phase 1 / Phase 2CompletedHaus Bioceuticals482016-02-292017-02-23
Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
HAT1, Calcipotriol - Psoriasis
Phase 2CompletedHaus Bioceuticals1742016-02-292019-02-21
Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
HAT1 topical solution, Calcipotriol - Psoriasis, Psoriasis Vulgaris
Phase 1 / Phase 2CompletedHaus Bioceuticals282012-01-062017-03-03

Conditions studied

Dermatitis, Atopic (3)  ·  Psoriasis (3)  ·  Eczema (2)

Interventions

calcipotriene (2)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Countries

India (1)

Top investigators

Mukta Sachdev, MD (1)  ·  P Alex, M.D. (1)